Literature DB >> 7781367

Transferrin concentrations in serum and lower respiratory tract fluid of mechanically ventilated patients with COPD or ARDS.

S W Stites1, M E Nelson, L J Wesselius.   

Abstract

Transferrin serves as the primary iron transport protein in serum, but it also is present in the lower respiratory tract where it has antioxidant and antibacterial properties. Prior studies indicate that patients with respiratory failure (RF) due to ARDS have increased concentrations of transferrin in the lower respiratory tract, which is attributed to increased lung vascular permeability. It is unclear whether mechanical ventilation contributes to increased lung transferrin content in patients with ARDS, although mechanical ventilation may increase lung microvascular permeability. To assess whether mechanical ventilation in patients with RF due to causes other than ARDS is also associated with increased respiratory tract concentrations of transferrin, we compared transferrin concentrations in serum and lung lavage fluid obtained from 12 mechanically ventilated patients with RF attributable to COPD, 6 patients with ARDS, and 15 healthy volunteers. Serum transferrin concentrations in patients with RF due to COPD were variable, but mean concentrations were similar to those in control subjects (336 +/- 58 vs 307 +/- 9 [SE] mg/dL), whereas serum transferrin concentrations were decreased in patients with ARDS (182 +/- 68 mg/dL; p < 0.05). Compared with control subjects, lavage fluid recovered from patients with RF due to COPD contained significantly decreased concentrations of transferrin (1.56 +/- 0.24 vs 4.27 +/- 0.44 micrograms/mL; p < 0.001), whereas transferrin concentrations in lavage fluid recovered from patients with ARDS were increased (15.72 +/- 2.01 micrograms/mL; p < 0.001). Transferrin concentrations of lavage fluid also were decreased in COPD patients when normalized for lavage fluid protein content (4.35 +/- 0.72 vs 19.96 +/- 3.13 micrograms/mg in control subjects, p < 0.001). These data indicate that mechanical ventilation of patients with COPD is associated with decreased lung transferrin concentrations, in contrast to an increased transferrin concentration found in patients with ARDS. Decreased transferrin concentrations in the lower respiratory tract may decrease defenses against oxidant injury and bacterial infection in patients with RF due to COPD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781367     DOI: 10.1378/chest.107.6.1681

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Site-specific conjugation of an antibody on a gold nanoparticle surface for one-step diagnosis of prostate specific antigen with dynamic light scattering.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Nanoscale       Date:  2017-06-29       Impact factor: 7.790

2.  Levels of transferrin in bronchoalveolar lavage fluid in sarcoidosis.

Authors:  Masahiko Shigemura; Yasuyuki Nasuhara; Satoshi Konno; Takeshi Hattori; Chikara Shimizu; Kazuhiko Matsuno; Masaharu Nishimura
Journal:  Lung       Date:  2010-04       Impact factor: 2.584

Review 3.  Iron metabolism in the lower respiratory tract.

Authors:  F Mateos; J H Brock; J L Pérez-Arellano
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

4.  New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors.

Authors:  Massimiliano Lucidi; Daniela Visaggio; Elisa Prencipe; Francesco Imperi; Giordano Rampioni; Gabriella Cincotti; Livia Leoni; Paolo Visca
Journal:  Appl Environ Microbiol       Date:  2019-08-29       Impact factor: 4.792

5.  Involvement of multiple distinct Bordetella receptor proteins in the utilization of iron liberated from transferrin by host catecholamine stress hormones.

Authors:  Sandra K Armstrong; Timothy J Brickman; Ryan J Suhadolc
Journal:  Mol Microbiol       Date:  2012-03-27       Impact factor: 3.501

6.  Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.

Authors:  Giuliano Bolondi; Emanuele Russo; Emiliano Gamberini; Alessandro Circelli; Manlio Cosimo Claudio Meca; Etrusca Brogi; Lorenzo Viola; Luca Bissoni; Venerino Poletti; Vanni Agnoletti
Journal:  World J Emerg Surg       Date:  2020-06-30       Impact factor: 5.469

7.  Association between iron status and the risk of adverse outcomes in COVID-19.

Authors:  Yanling Lv; Liangkai Chen; Xiaoling Liang; Xiaohui Liu; Ming Gao; Qiang Wang; Qing Wei; Liegang Liu
Journal:  Clin Nutr       Date:  2020-12-09       Impact factor: 7.324

8.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

9.  Secretoglobin and Transferrin Expression in Bronchoalveolar Lavage Fluid of Horses with Chronic Respiratory Disease.

Authors:  M Miskovic Feutz; L L Couetil; C P Riley; X Zhang; J Adamec; R E Raskin
Journal:  J Vet Intern Med       Date:  2015-08-30       Impact factor: 3.333

10.  Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease.

Authors:  Nan He; Xiaoming Liu; Amber R Vegter; T Idil A Evans; Jaimie S Gray; Junfeng Guo; Shashanna R Moll; Lydia J Guo; Meihui Luo; Ningxia Ma; Xingshen Sun; Bo Liang; Ziying Yan; Zehua Feng; Lisi Qi; Arnav S Joshi; Weam Shahin; Yaling Yi; Katherine N Gibson-Corley; Eric A Hoffman; Kai Wang; Christian Mueller; John F Engelhardt; Bradley H Rosen
Journal:  JCI Insight       Date:  2022-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.